Physician profile
Bilal M Murad
NPI 1922066901
$16,817.36
in general payments reported to CMS, 2019-2025
15 companies · $4,206 in 2025
The $4,206 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,209 · 2020: $441 · 2021: $542 · 2022: $3,323 · 2023: $1,043 · 2024: $5,054 · 2025: $4,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,889 · Consulting Fee: $2,813 · Travel and Lodging: $1,801 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,889.40 |
| Consulting Fee | $2,812.50 |
| Travel and Lodging | $1,800.98 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,828.51 | 2019-2025 | Avvigo Guidance System, Stingray, General - Therapies |
| Edwards Lifesciences Corporation | $3,780.16 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $2,988.89 | 2019-2025 | Coroflow, Ultreon, Mitraclip |
| Shockwave Medical, INC | $1,974.51 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Siemens Medical Solutions USA, INC. | $1,293.88 | 2022 | |
| Corindus INC. | $1,286.96 | 2019 | |
| Abiomed | $567.22 | 2019-2025 | Impella |
| Medtronic, INC. | $441.89 | 2021-2023 | Corevalve Evolut R |
| Cardiovascular Systems INC. | $206.65 | 2020-2022 | |
| Zoll Circulation INC | $193.96 | 2024-2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Teleflex LLC | $151.12 | 2023 | Guideliner |
| Penumbra, INC. | $44.55 | 2019 | |
| Heartflow, INC. | $26.82 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $17.13 | 2025 | Camzyos |
| Pfizer INC. | $15.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Murad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.